SPBC2A9.07c Antibody

What is SPBC2A9.07c and what is its functional significance in fission yeast?

SPBC2A9.07c encodes a protein named Hpz1 (Homologue of PARP-type Zn-finger) in Schizosaccharomyces pombe (fission yeast). Research has established that Hpz1 contains a PARP-type Zn-finger domain that shows extensive homology to the Poly(ADP-ribose) polymerase Zn-finger motif, although it lacks other features necessary for PARP function .

Functionally, Hpz1 appears to be involved in DNA replication control and cell cycle regulation, particularly at the G1-S transition. Studies have demonstrated that deletion of hpz1 affects the timing of MCM loading in G1 phase, with maximum loading occurring approximately 15 minutes earlier in hpz1Δ cells compared to wild-type cells . This suggests that Hpz1 negatively modulates events at or before Pre-replicative complex (PreRC) formation. Unlike PARP proteins in higher eukaryotes, there is no evidence for poly(ADP-ribosyl)ated proteins in fission yeast cell extracts, indicating Hpz1 likely has different functions than canonical PARP-mediated DNA repair .

How is Hpz1 (SPBC2A9.07c) related to Rad3 and DNA damage response pathways?

Research indicates that Hpz1 may function as a partner for Rad3 in fission yeast. This partnership was identified through comparative genomic analysis, which revealed that in several fungi, the Rad3 homologue contains an additional C-terminal motif with extensive homology to the PARP-type Zn-finger domain . In fission yeast, this motif is encoded by the separate gene SPBC2A9.07c (Hpz1).

The functional relationship between Hpz1 and Rad3 is supported by several experimental observations:

• The hpz1 deletion mutant shows increased sensitivity to UV radiation, although to a lesser degree than rad3 deletion mutants

• After hydroxyurea (HU) treatment and release, approximately 7% of hpz1Δ cells display the "cut" phenotype, which is characteristic of checkpoint defects

• Co-immunoprecipitation experiments have detected interaction between Hpz1-HA and Rad3-myc in extracts from untreated G1 cells and HU-treated cells

These findings suggest that while Hpz1 is not essential for checkpoint function, it plays a supporting role in the Rad3-mediated response to DNA damage and replication stress.

What validation methods should be used to confirm SPBC2A9.07c antibody specificity?

Validating SPBC2A9.07c antibody specificity requires a multi-faceted approach:

• Genetic validation: Compare antibody reactivity in wild-type and hpz1Δ (knockout) strains using Western blot analysis. The absence of signal in knockout samples provides strong evidence of specificity .

• Epitope-tagged controls: Co-detection with epitope-tagged versions of the protein (e.g., Hpz1-HA or Hpz1-GFP) can confirm antibody specificity. For instance, in co-immunoprecipitation experiments, researchers successfully used Hpz1-HA constructs that could be detected with both anti-HA and anti-Hpz1 antibodies .

• Recombinant protein controls: Express and purify recombinant Hpz1 protein to use as a positive control in Western blots and for pre-absorption tests to confirm binding specificity .

• Cross-reactivity assessment: Test the antibody against related proteins (such as SPAC13F5.07c, the other fission yeast protein with PARP-type Zn-finger domain) to rule out cross-reactivity .

• Multiple antibody comparison: When available, compare results using multiple antibodies targeting different epitopes of Hpz1 .

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry analysis to confirm the identity of the protein being recognized by the antibody .

What are the optimal fixation and immunostaining protocols for SPBC2A9.07c detection in different applications?

The choice of fixation and immunostaining protocol depends on the specific application and subcellular localization being investigated:

For immunofluorescence microscopy:

• For general cellular localization, fix cells with 3.7% formaldehyde for 30 minutes at room temperature

• For nuclear protein detection, methanol fixation (-20°C for 6 minutes) followed by acetone treatment (-20°C for 30 seconds) may better preserve nuclear structures

• Include cell wall digestion with zymolyase (1mg/ml for 30 minutes) for fission yeast cells

• Permeabilize with 0.1-0.5% Triton X-100 for 5 minutes

For chromatin-associated protein detection:

• Pre-extract soluble proteins with 0.1% Triton X-100 in PIPES-EGTA-Magnesium buffer before fixation

• Use shorter fixation times (10-15 minutes) to minimize epitope masking

For flow cytometry:

• Fix cells with 1-2% paraformaldehyde for 15 minutes

• Permeabilize with 0.1% Triton X-100 or 90% methanol depending on epitope accessibility

For chromatin immunoprecipitation (ChIP):

• Crosslink with 1% formaldehyde for 15 minutes at room temperature

• Quench with 125mM glycine for 5 minutes

• Optimize sonication conditions to achieve chromatin fragments of 200-500bp

How should researchers design experiments to study Hpz1-Rad3 interactions?

To effectively study Hpz1-Rad3 interactions, consider the following experimental design strategies:

• Cell synchronization approaches: Since the interaction between Hpz1 and Rad3 appears to be cell cycle-dependent, synchronize cells using cdc10 block-and-release to study G1 phase interactions or cdc25 block-and-release for G2 phase studies .

• Stress induction protocols: Apply hydroxyurea (15mM) to induce replication stress or UVC irradiation (50-300J/m²) to induce DNA damage, as both conditions may enhance Hpz1-Rad3 interactions .

• Co-immunoprecipitation optimization: Use mild detergent conditions (0.1-0.5% NP-40) in immunoprecipitation buffer containing phosphatase inhibitors (60mM glycerophosphate, 15mM ρ-nitrophenylphosphate) and protease inhibitors to preserve potentially transient interactions .

• Epitope tag selection: Consider using multiple epitope tags (HA, myc, GFP) and test different tag positions (N-terminal vs. C-terminal) as the location may affect protein interactions .

• Sequential ChIP (re-ChIP): To identify genomic regions where Hpz1 and Rad3 co-localize, perform sequential ChIP using antibodies against both proteins.

• Proximity ligation assays: Use this technique to visualize in situ protein-protein interactions with higher sensitivity than traditional co-localization studies.

• Genetic interaction studies: Compare phenotypes of single (hpz1Δ, rad3Δ) and double (hpz1Δ rad3Δ) mutants under different stress conditions to identify epistatic relationships .

What controls are essential when studying SPBC2A9.07c localization and dynamics during cell cycle progression?

When studying SPBC2A9.07c localization and dynamics during cell cycle progression, the following controls are essential:

• Cell cycle markers: Include parallel staining for established cell cycle phase markers such as MCM proteins for PreRC formation , PCNA for S phase, and tubulin for mitosis.

• Synchronization validation: Confirm cell cycle synchronization by flow cytometry analysis of DNA content and/or morphological assessment of synchronized cultures.

• Multiple time points: Collect samples at multiple time points after synchronization release to capture the dynamic nature of Hpz1 localization throughout the cell cycle. Previous studies examined MCM loading at 15-minute intervals following release from cdc10 block .

• Technical controls for immunostaining:

  • Include secondary antibody-only controls to assess background staining

  • Include wild-type and hpz1Δ strains processed in parallel

  • Use co-staining with organelle markers to confirm subcellular localization

• Quantitative analysis: Employ quantitative image analysis to measure signal intensity and co-localization throughout the cell cycle, normalizing to appropriate reference proteins.

• Complementary approaches: Validate immunofluorescence findings with biochemical fractionation experiments to track Hpz1 association with different cellular compartments during cell cycle progression.

How can SPBC2A9.07c antibodies be used to investigate the role of Hpz1 in regulating DNA replication and repair?

SPBC2A9.07c antibodies can be employed in several advanced applications to explore Hpz1's role in DNA replication and repair:

• ChIP-seq analysis: Perform chromatin immunoprecipitation followed by next-generation sequencing to identify genomic binding sites of Hpz1, particularly near origins of replication. Compare binding profiles between normal conditions and after UV or HU treatment to identify stress-responsive changes .

• Pulse-chase immunoprecipitation: Combine metabolic labeling with immunoprecipitation to track newly synthesized Hpz1 and its incorporation into protein complexes during normal replication versus replication stress conditions.

• Protein-protein interaction networks: Use SPBC2A9.07c antibodies for immunoprecipitation followed by mass spectrometry to identify interaction partners in different cell cycle phases or stress conditions. This approach can reveal how Hpz1 functions within larger protein complexes .

• Post-translational modification analysis: Immunoprecipitate Hpz1 and analyze for post-translational modifications (phosphorylation, ubiquitination, etc.) by mass spectrometry, especially after DNA damage or replication stress.

• Replication fork progression analysis: Combine DNA fiber analysis with immunofluorescence to correlate Hpz1 localization with replication fork dynamics, particularly in response to replication stress.

• Super-resolution microscopy: Employ techniques like STORM or PALM with SPBC2A9.07c antibodies to visualize Hpz1 localization at the nanoscale level, potentially revealing its organization at replication factories or DNA damage sites.

• In vitro reconstitution assays: Use purified components including Hpz1 (detected with SPBC2A9.07c antibodies) to reconstitute aspects of replication initiation or stalled fork processing in controlled biochemical systems.

What approaches can be used to study potential regulatory relationships between Hpz1 and chromatin structure?

To investigate potential regulatory relationships between Hpz1 and chromatin structure:

• ChIP-seq with histone modification antibodies: Perform parallel ChIP-seq for Hpz1 and various histone modifications (H3K4me3, H3K9me3, H3K27ac, etc.) to identify correlations between Hpz1 binding and specific chromatin states.

• Nucleosome positioning analysis: Compare MNase-seq profiles between wild-type and hpz1Δ strains to determine if Hpz1 affects nucleosome positioning, particularly at replication origins or transcription start sites.

• Chromatin accessibility assays: Perform ATAC-seq or DNase-seq in wild-type and hpz1Δ strains to determine if Hpz1 influences chromatin accessibility.

• Histone deacetylase inhibitor studies: Treat cells with histone deacetylase inhibitors like TSA and examine effects on Hpz1 localization and function. Research on fission yeast G0 nuclei has shown that TSA treatment affects histone acetylation patterns .

• Chromatin fractionation: Use biochemical fractionation followed by immunoblotting with SPBC2A9.07c antibodies to determine Hpz1 distribution between soluble nuclear and chromatin-bound fractions under different conditions.

• Protein domain analysis: Generate truncated or mutated versions of Hpz1 lacking the PARP-type Zn-finger domain and assess effects on chromatin association and function, providing insights into how this domain contributes to Hpz1's role in chromatin regulation.

• Chromatin interaction analysis: Apply techniques like Hi-C or Micro-C in wild-type and hpz1Δ strains to determine if Hpz1 influences higher-order chromatin organization.

How can researchers troubleshoot inconsistent results when using SPBC2A9.07c antibodies?

When encountering inconsistent results with SPBC2A9.07c antibodies, systematically address these potential issues:

• Antibody specificity issues:

  • Validate antibody specificity using hpz1Δ strains as negative controls

  • Test different antibody lots and storage conditions

  • Consider using alternative antibodies targeting different epitopes

• Cell cycle-dependent variations:

  • Synchronize cell populations to ensure consistent cell cycle distribution

  • Include cell cycle markers in your analysis

  • Be aware that Hpz1-Rad3 interactions appear to be cell cycle-specific

• Sample preparation problems:

  • Optimize lysis conditions to ensure complete extraction of Hpz1 (nuclear proteins often require stronger extraction methods)

  • Include phosphatase and protease inhibitors in all buffers

  • For fixed samples, test different fixation methods as they can affect epitope accessibility

• Detection sensitivity limitations:

  • Use signal amplification methods for low-abundance proteins

  • Optimize primary and secondary antibody concentrations through titration experiments

  • Consider using more sensitive detection systems (e.g., enhanced chemiluminescence or fluorescent secondary antibodies)

• Transient protein interactions:

  • Use chemical crosslinking to stabilize transient interactions

  • Try different detergent concentrations in immunoprecipitation buffers

  • Consider rapid isolation techniques to capture short-lived complexes

• Technical considerations:

  • Include appropriate loading controls and normalization methods

  • Be consistent with sample handling times and temperatures

  • Document all experimental parameters to identify sources of variation

How should researchers interpret differences in experimental results between genetic and antibody-based approaches when studying Hpz1 function?

When interpreting discrepancies between genetic and antibody-based approaches in Hpz1 studies:

• Consider the nature of genetic modifications:

  • Complete gene deletion (hpz1Δ) eliminates all protein functions, while antibody inhibition or epitope tagging may affect only specific interactions or functions

  • Point mutations may create separation-of-function alleles that reveal specific aspects of Hpz1 function not detected by antibody approaches

• Evaluate epitope accessibility issues:

  • Antibodies may not detect Hpz1 in certain protein complexes due to epitope masking

  • Post-translational modifications may alter epitope recognition

  • Different fixation methods can significantly affect epitope accessibility in microscopy applications

• Assess potential compensation mechanisms:

  • Chronic loss of Hpz1 in genetic mutants may trigger compensatory mechanisms not present in acute antibody inhibition experiments

  • The related protein SPAC13F5.07c might partially compensate for Hpz1 loss in genetic mutants

• Consider protein dosage effects:

  • Overexpression or tagged protein systems may not recapitulate endogenous expression levels

  • Partial antibody inhibition versus complete genetic deletion can reveal dosage-dependent functions

• Integrate multiple approaches:

  • Use complementary techniques (genetics, biochemistry, microscopy) and look for convergent evidence

  • Design experiments where genetic and antibody approaches can be directly compared in the same system

  • When possible, use antibody-based detection of endogenous protein alongside tagged protein detection for validation

• Context-dependent functions:

  • Consider that Hpz1 may have different functions in different cellular contexts (normal growth vs. stress conditions)

  • The minor increase in UV sensitivity of hpz1Δ compared to the severe phenotype of rad3Δ suggests context-specific roles

Table 3: Recommended Antibody Applications for SPBC2A9.07c/Hpz1 Research